Literature DB >> 24184781

Manganese in human parenteral nutrition: considerations for toxicity and biomonitoring.

Dinamene Santos1, Camila Batoreu1, Luisa Mateus1, A P Marreilha Dos Santos1, Michael Aschner2.   

Abstract

The iatrogenic risks associated with excessive Mn administration in parenteral nutrition (PN) patients are well documented. Hypermanganesemia and neurotoxicity are associated with the duration of Mn supplementation, Mn dosage, as well as pathological conditions, such as anemia or cholestasis. Recent PN guidelines recommend the biomonitoring of patients if they receive Mn in their PN longer than 30 days. The data in the literature are conflicting about the method for assessing Mn stores in humans as a definitive biomarker of Mn exposure or induced-neurotoxicity has yet to be identified. The biomonitoring of Mn relies on the analysis of whole blood Mn (WB Mn) levels, which are highly variable among human population and are not strictly correlated with Mn-induced neurotoxicity. Alterations in dopaminergic (DAergic) and catecholaminergic metabolism have been studied as predictive biomarkers of Mn-induced neurotoxicity. Given these limitations, this review addresses various approaches for biomonitoring Mn exposure and neurotoxic risk.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomonitoring; Manganese; Neurotoxicity; Parenteral nutrition

Mesh：

Substances：

Year:  2013        PMID： 24184781      PMCID： PMC4007395          DOI： 10.1016/j.neuro.2013.10.003

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN： 0161-813X            Impact factor:   4.294


  139 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

2.  Safe practices for parenteral nutrition.

Authors:  Jay Mirtallo; Todd Canada; Deborah Johnson; Vanessa Kumpf; Craig Petersen; Gordon Sacks; David Seres; Peggi Guenter
Journal:  JPEN J Parenter Enteral Nutr       Date:  2004 Nov-Dec       Impact factor: 4.016

3.  Hepatic steatosis in total parenteral nutrition: failure of fatty infiltration to correlate with abnormal serum hepatic enzyme levels.

Authors:  H C Sax; M A Talamini; K Brackett; J E Fischer
Journal:  Surgery       Date:  1986-10       Impact factor: 3.982

4.  Regional cerebral metabolism in mouse under chronic manganese exposure: implications for manganism.

Authors:  Puneet Bagga; Anant Bahadur Patel
Journal:  Neurochem Int       Date:  2011-11-13       Impact factor: 3.921

5.  A manganese-enhanced diet alters brain metals and transporters in the developing rat.

Authors:  Stephanie J Garcia; Kristin Gellein; Tore Syversen; Michael Aschner
Journal:  Toxicol Sci       Date:  2006-05-16       Impact factor: 4.849

6.  Neurologic disorders due to brain manganese deposition in a jaundiced patient receiving long-term parenteral nutrition.

Authors:  G Alves; J Thiebot; A Tracqui; T Delangre; C Guedon; E Lerebours
Journal:  JPEN J Parenter Enteral Nutr       Date:  1997 Jan-Feb       Impact factor: 4.016

7.  Manganese metabolism is impaired in the Belgrade laboratory rat.

Authors:  A C Chua; E H Morgan
Journal:  J Comp Physiol B       Date:  1997-07       Impact factor: 2.200

8.  Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature.

Authors:  S Nagatomo; F Umehara; K Hanada; Y Nobuhara; S Takenaga; K Arimura; M Osame
Journal:  J Neurol Sci       Date:  1999-01-01       Impact factor: 3.181

Review 9.  Manganese in parenteral nutrition: who, when, and why should we supplement?

Authors:  Gil Hardy
Journal:  Gastroenterology       Date:  2009-11       Impact factor: 22.682

10.  Plasma manganese concentrations in infants and children receiving parenteral nutrition.

Authors:  K M Hambidge; R J Sokol; S J Fidanza; M A Goodall
Journal:  JPEN J Parenter Enteral Nutr       Date:  1989 Mar-Apr       Impact factor: 4.016
View more
  14 in total

1.  A compact DD neutron generator-based NAA system to quantify manganese (Mn) in bone in vivo.

Authors:  Yingzi Liu; Patrick Byrne; Haoyu Wang; David Koltick; Wei Zheng; Linda H Nie
Journal:  Physiol Meas       Date:  2014-08-26       Impact factor: 2.833

2.  Manganese transport and toxicity in polarized WIF-B hepatocytes.

Authors:  Khristy J Thompson; Jennifer Hein; Andrew Baez; Jose Carlo Sosa; Marianne Wessling-Resnick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-24       Impact factor: 4.052

Review 3.  Influence of iron metabolism on manganese transport and toxicity.

Authors:  Qi Ye; Jo Eun Park; Kuljeet Gugnani; Swati Betharia; Alejandro Pino-Figueroa; Jonghan Kim
Journal:  Metallomics       Date:  2017-08-16       Impact factor: 4.526

4.  Diphenyl Diselenide Protects Against Mortality, Locomotor Deficits and Oxidative Stress in Drosophila melanogaster Model of Manganese-Induced Neurotoxicity.

Authors:  Isaac A Adedara; Amos O Abolaji; Joao B T Rocha; Ebenezer O Farombi
Journal:  Neurochem Res       Date:  2016-02-15       Impact factor: 3.996

5.  Neuroimaging identifies increased manganese deposition in infants receiving parenteral nutrition.

Authors:  Judy L Aschner; Adam Anderson; James Christopher Slaughter; Michael Aschner; Steven Steele; Amy Beller; Amanda Mouvery; Heather M Furlong; Nathalie L Maitre
Journal:  Am J Clin Nutr       Date:  2015-11-11       Impact factor: 7.045

6.  Manganese toxicity in critical care: Case report, literature review and recommendations for practice.

Authors:  Edward Walter; Sinan Alsaffar; Callum Livingstone; Sarah L Ashley
Journal:  J Intensive Care Soc       Date:  2015-12-10

7.  Manganese transporter Slc30a10 controls physiological manganese excretion and toxicity.

Authors:  Courtney J Mercadante; Milankumar Prajapati; Heather L Conboy; Miriam E Dash; Carolina Herrera; Michael A Pettiglio; Layra Cintron-Rivera; Madeleine A Salesky; Deepa B Rao; Thomas B Bartnikas
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

8.  Nutritive Manganese and Zinc Overdosing in Aging C. elegans Result in a Metallothionein-Mediated Alteration in Metal Homeostasis.

Authors:  Jessica Baesler; Vivien Michaelis; Michael Stiboller; Hajo Haase; Michael Aschner; Tanja Schwerdtle; Stephen R Sturzenbaum; Julia Bornhorst
Journal:  Mol Nutr Food Res       Date:  2021-03-09       Impact factor: 5.914

Review 9.  Evaluating the risk of manganese-induced neurotoxicity of parenteral nutrition: review of the current literature.

Authors:  Airton C Martins; Silvana Ruella Oliveira; Fernando Barbosa; Alexey A Tinkov; Anatoly V Skalny; Abel Santamaría; Eunsook Lee; Aaron B Bowman; Michael Aschner
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-03-04       Impact factor: 4.481

10.  Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia.

Authors:  Karin Tuschl; Esther Meyer; Leonardo E Valdivia; Ningning Zhao; Chris Dadswell; Alaa Abdul-Sada; Christina Y Hung; Michael A Simpson; W K Chong; Thomas S Jacques; Randy L Woltjer; Simon Eaton; Allison Gregory; Lynn Sanford; Eleanna Kara; Henry Houlden; Stephan M Cuno; Holger Prokisch; Lorella Valletta; Valeria Tiranti; Rasha Younis; Eamonn R Maher; John Spencer; Ania Straatman-Iwanowska; Paul Gissen; Laila A M Selim; Guillem Pintos-Morell; Wifredo Coroleu-Lletget; Shekeeb S Mohammad; Sangeetha Yoganathan; Russell C Dale; Maya Thomas; Jason Rihel; Olaf A Bodamer; Caroline A Enns; Susan J Hayflick; Peter T Clayton; Philippa B Mills; Manju A Kurian; Stephen W Wilson
Journal:  Nat Commun       Date:  2016-05-27       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.